Head-to-head · WeighScore
Alternate Health Club vs GoodRx
The verdict
Alternate Health Club takes it — 69.8/100 to 69.6/100, but only just.
Alternate Health Club grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Alternate Health Club (alternatehealthclub.com) is a LegitScript-verified compounded GLP-1 telehealth platform offering compounded semaglutide at $129/month and compounded tirzepatide at $169/month. GoodRx is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Alternate Health Club | GoodRx |
|---|---|---|
| WeighScore | 69.8/100 | 69.6/100 |
| Grade | C | C |
| Scorecard rank | #111 | #116 |
| Semaglutide | $129/mo (compounded) | Not disclosed |
| Tirzepatide | $169/mo (compounded) | $299/mo (brand Zepbound) |
| Coverage | Coverage not published | All 50 states |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Injection only |
Graded #111 · C
Strengths
- $129/month compounded semaglutide is among the cheapest in the US market
- $169/month compounded tirzepatide is competitive with established platforms
- Complimentary workout and dietary plans bundled with medication — most peers don't
- LegitScript verified
- US-licensed clinicians
Where it loses points
- Parent company / legal entity not publicly disclosed
- State of incorporation not disclosed
- Per-state availability not listed — confirm your state ships before committing
- Pharmacy partners not publicly named
- Unclear whether lab work is included
Graded #116 · C
Strengths
- $149/month self-pay for brand-name Foundayo (orforglipron) — matches the lowest cash price at launch, far below typical retail
- $299/month self-pay for Zepbound KwikPen — well under Lilly's typical cash list price
- Honored at 70,000+ US pharmacies — the largest retail redemption network of any GLP-1 channel we cover
- No membership fee — bring your own prescription and present the discount card at the pharmacy counter
- Brand-name FDA-approved medication, not compounded
Where it loses points
- Requires a valid prescription — GoodRx is a discount card, not a prescriber; you still need a clinician to write the script
- Self-pay only — does not apply toward insurance benefits or deductibles
- Headline price applies to the lowest Foundayo dose; higher doses may cost more
- No compounded GLP-1 options — not the channel for compounded semaglutide or tirzepatide
- Pricing can change as Lilly's manufacturer coupon program evolves
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.